CT and MR imaging of hepatic metastases.

[1]  R. Edelman,et al.  MR imaging of liver metastases at 1.5 T: similar contrast discrimination with T1- and T2-weighted pulse sequences. , 1991, Radiology.

[2]  R. Semelka,et al.  Malignant liver lesions: Comparison of spiral CT arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management , 1996, Journal of magnetic resonance imaging : JMRI.

[3]  A Giovagnoni,et al.  Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg). , 1996, Magnetic resonance imaging clinics of North America.

[4]  T. Vogl,et al.  Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients. , 1992, Radiology.

[5]  G. Bačić,et al.  Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn‐DPDP , 1996, Magnetic resonance in medicine.

[6]  P. Choyke,et al.  Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings. , 1989, Surgery.

[7]  Y. Yamashita,et al.  MR imaging of the liver: comparison between single-shot echo-planar and half-Fourier rapid acquisition with relaxation enhancement sequences. , 1998, Radiology.

[8]  Y. Yamashita,et al.  Differential diagnosis of focal liver lesions: role of spin-echo and contrast-enhanced dynamic MR imaging. , 1994, Radiology.

[9]  C. Reinhold,et al.  Effect of rate of contrast medium injection on hepatic enhancement at CT. , 1996, Radiology.

[10]  A Pfefferbaum,et al.  Hepatobiliary MR imaging: first human experience with MnDPDP. , 1991, Radiology.

[11]  E. Fishman,et al.  CT during arterial portography for the preoperative evaluation of hepatic tumors: how, when, and why? , 1994, AJR. American journal of roentgenology.

[12]  L. V. Van Hoe,et al.  Dual-phase helical CT of the liver: value of an early-phase acquisition in the differential diagnosis of noncystic focal lesions. , 1997, AJR. American journal of roentgenology.

[13]  P. Soyer,et al.  False-positive CT portography: correlation with pathologic findings. , 1993, AJR. American journal of roentgenology.

[14]  R M Gore,et al.  Using triphasic helical CT to detect focal hepatic lesions in patients with neoplasms. , 1998, AJR. American journal of roentgenology.

[15]  M. Mack,et al.  Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. , 1996, Radiology.

[16]  C. Johnson,et al.  Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns. , 1995, AJR. American journal of roentgenology.

[17]  E. D. de Lange,et al.  MR imaging of the liver: breath-hold T1-weighted MP-GRE compared with conventional T2-weighted SE imaging--lesion detection, localization, and characterization. , 1994, Radiology.

[18]  Contrast agents for MR imaging of the liver , 1997, Journal of magnetic resonance imaging : JMRI.

[19]  P M Silverman,et al.  Helical CT of the liver: clinical application of an automated computer technique, SmartPrep, for obtaining images with optimal contrast enhancement. , 1995, AJR. American journal of roentgenology.

[20]  K. Wolf,et al.  Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. , 1994, Radiology.

[21]  T. Murakami,et al.  Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. , 1996, Radiology.

[22]  H. Hasegawa,et al.  Peripheral low-density area of hepatic tumors: CT-pathologic correlation. , 1986, Radiology.

[23]  R. Semelka,et al.  Liver lesion detection, characterization, and effect on patient management: Comparison of single‐phase spiral CT and current MR techniques , 1997, Journal of magnetic resonance imaging : JMRI.

[24]  D. DeLong,et al.  Carcinoid metastases to the liver: role of triple-phase helical CT. , 1998, Radiology.

[25]  Y. Ni,et al.  Effect of manganese dipyridoxal diphosphate on liver magnetic resonance imaging and serum bilirubin in rats with removable biliary obstruction. , 1995, Academic radiology.

[26]  R. Weissleder,et al.  Differentiation of hepatic metastases from hepatic hemangiomas and cysts by using MR imaging. , 1988, AJR. American journal of roentgenology.

[27]  V. Runge,et al.  Contrast‐enhanced MR imaging of the liver , 1994, Journal of magnetic resonance imaging : JMRI.

[28]  P. Soyer,et al.  Detection of focal hepatic lesions with MR imaging: prospective comparison of T2-weighted fast spin-echo with and without fat suppression, T2-weighted breath-hold fast spin-echo, and gadolinium chelate-enhanced 3D gradient-recalled imaging. , 1996, AJR. American journal of roentgenology.

[29]  R. Baron,et al.  Understanding and optimizing use of contrast material for CT of the liver. , 1994, AJR. American journal of roentgenology.

[30]  R. Weissleder,et al.  Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review. , 1996, Magnetic resonance imaging clinics of North America.

[31]  M. Taupitz,et al.  Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? , 1997, Radiology.

[32]  C. Johnson,et al.  Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases. , 1995, AJR. American journal of roentgenology.

[33]  M. Bernardino,et al.  Combined CT arterial portography and CT hepatic angiography for evaluation of the hepatic resection candidate. Work in progress. , 1993, Radiology.

[34]  E. Holtz,et al.  Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. , 1994, Investigative radiology.

[35]  P. Mergo,et al.  Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions. , 1996, AJR. American journal of roentgenology.

[36]  M. Choti,et al.  Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings. , 1996, AJR. American journal of roentgenology.

[37]  R B Jeffrey,et al.  Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. , 1995, AJR. American journal of roentgenology.

[38]  R. Semelka,et al.  Malignant lesions of the liver identified on T1‐ but not T2‐weighted MR images at 1.5 T , 1994, Journal of magnetic resonance imaging : JMRI.

[39]  M. Baker,et al.  Hepatic metastases: basic principles and implications for radiologists. , 1995, Radiology.

[40]  J. Mintorovitch,et al.  Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents. , 1997, Radiology.

[41]  R. Edelman,et al.  Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. , 1994, Radiology.

[42]  E. Fishman,et al.  Spiral CT during arterial portography: technique and applications. , 1995, Radiographics : a review publication of the Radiological Society of North America, Inc.

[43]  T. Murakami,et al.  Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP). , 1996, Radiology.

[44]  M. Bernardino,et al.  Focal hepatic lesions: comparative MR imaging at 0.5 and 1.5 T. , 1990, Radiology.

[45]  B. V. Van Beers,et al.  Contrast-enhanced MR imaging of the liver. , 1997, Radiology.

[46]  T J O'Leary,et al.  CT of the liver and spleen with EOE-13: review of 225 examinations. , 1984, AJR. American journal of roentgenology.

[47]  N. Ackerman,et al.  The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors. , 1969, Surgery.

[48]  J. Figueras,et al.  Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma. , 1998, AJR. American journal of roentgenology.

[49]  M. Reiser,et al.  Comparison between high-field-strength MR imaging and CT for screening of hepatic metastases: a receiver operating characteristic analysis. , 1992, Radiology.

[50]  Y Himeno,et al.  Hepatic hemangioma: findings with two-phase CT. , 1995, Radiology.

[51]  W. Pegios,et al.  Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. , 1996, Radiology.

[52]  R H Hruban,et al.  Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography. , 1994, Radiology.

[53]  C. Reinhold,et al.  Helical CT of the liver: value of an early hepatic arterial phase. , 1995, Radiology.

[54]  M S van Leeuwen,et al.  Focal liver lesions: characterization with triphasic spiral CT. , 1996, Radiology.

[55]  G. Dodd,et al.  Investigation of contrast enhancement in CT of the liver: the need for improved methods. , 1993, AJR. American journal of roentgenology.

[56]  A. Kopp,et al.  Liver-specific contrast media: a magic bullet or a weapon for dedicated targets? , 1997, Radiology.

[57]  S S Sagel,et al.  Dynamic contrast-enhanced CT of the liver: comparison of contrast medium injection rates and uniphasic and biphasic injection protocols. , 1993, Radiology.

[58]  C. Balu-Maestro,et al.  Liver, spleen, and vessels: preliminary clinical results of CT with perfluorooctylbromide. , 1989, Radiology.

[59]  Y. Ni,et al.  Mn-DPDP enhanced MRI in experimental bile duct obstruction. , 1993, Journal of computer assisted tomography.

[60]  D. Khayat,et al.  Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. , 1994, Radiology.

[61]  H. Kressel,et al.  Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. , 1991, Radiology.

[62]  T. Murakami,et al.  Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). , 1996, Radiology.

[63]  M Takahashi,et al.  Liver T2-weighted MR imaging: comparison of fast and conventional half-Fourier single-shot turbo spin-echo, breath-hold turbo spin-echo, and respiratory-triggered turbo spin-echo sequences. , 1997, Radiology.

[64]  R. Semelka,et al.  Malignant lesions of the liver with high signal intensity on T1‐Weighted MR images , 1996, Journal of magnetic resonance imaging : JMRI.

[65]  J. Weinreb,et al.  Extension of vessels through hepatic neoplasms: MR and CT findings. , 1994, Radiology.

[66]  R C Nelson,et al.  Helical liver CT with computer-assisted bolus-tracking technology: is it possible to predict which patients will not achieve a threshold of enhancement? , 1998, Radiology.

[67]  F C Simm,et al.  Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T. , 1992, Radiology.

[68]  B. V. Van Beers,et al.  Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. , 1996, Radiology.

[69]  J G Hennessey,et al.  Detection of focal hepatic lesions with spiral CT: comparison of 4- and 8-mm interscan spacing. , 1993, AJR. American journal of roentgenology.

[70]  S E Seltzer,et al.  Prospective comparison of T2-weighted fast spin-echo, with and without fat suppression, and conventional spin-echo pulse sequences in the upper abdomen. , 1993, Radiology.

[71]  D. Bluemke,et al.  CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. , 1994, AJR. American journal of roentgenology.

[72]  J. Heiken,et al.  Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. , 1989, Radiology.